121-135 of 401
Evaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
DermConsultEvaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
Amy Paller, MS, MD
The Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
DermConsultThe Far-Reaching Impacts of Psoriasis: Understanding and Mitigating Risks
Jenny Murase, MD
Sodium Intake and Psoriasis: New Evidence Linking Diet and Skin Health
DermConsultSodium Intake and Psoriasis: New Evidence Linking Diet and Skin Health
Katrina Abuabara, MD, FAAD
Psoriasis Risks and Variants: Educating Patients to Optimize Outcomes
DermConsultPsoriasis Risks and Variants: Educating Patients to Optimize Outcomes
Jenny Murase, MD
Four-Year Efficacy & Safety of Deucravacitinib in Plaque Psoriasis
DermConsultFour-Year Efficacy & Safety of Deucravacitinib in Plaque Psoriasis
- advertisement
Genetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
On the Frontlines of PsoriasisGenetics in Psoriasis: Impacts on Risk, Comorbidities, and Care
Audrey Bui, DO
Helping Kids Thrive: Addressing Eczema Early with Systemic Therapies
DermConsultHelping Kids Thrive: Addressing Eczema Early with Systemic Therapies
Peter A. Lio, MD
Advances in Pediatric Eczema Care: Emerging Biologics, JAK Inhibitors, and Beyond
DermConsultAdvances in Pediatric Eczema Care: Emerging Biologics, JAK Inhibitors, and Beyond
Peter A. Lio, MD
Addressing Unmet Needs in Pediatric Atopic Dermatitis: Equity, Access, and Advocacy
DermConsultAddressing Unmet Needs in Pediatric Atopic Dermatitis: Equity, Access, and Advocacy
Peter A. Lio, MD
Addressing Mental Health Impacts of Skin Disease in Adolescents and Young Adults
DermConsultAddressing Mental Health Impacts of Skin Disease in Adolescents and Young Adults
Nicholas D. Brownstone, MD
Acne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
DermConsultAcne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
Nicholas D. Brownstone, MD
- advertisement
Dupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
DermConsultDupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
Skin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
On the Frontlines of PsoriasisSkin Disease and Cardiovascular Risk: Uncovering a Critical Clinical Connection
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Joel M. Gelfand, MD, MSCE, FAAD
Michael S. Garshick, MD
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
